BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -37.5% | 13,768 | 0.0% | 0.00% | – |
| Q2 2022 | $16,000 | -27.3% | 13,768 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | -31.2% | 13,768 | 0.0% | 0.00% | – |
| Q4 2021 | $32,000 | +6.7% | 13,768 | 0.0% | 0.00% | – |
| Q3 2021 | $30,000 | -23.1% | 13,768 | 0.0% | 0.00% | – |
| Q2 2021 | $39,000 | -25.0% | 13,768 | 0.0% | 0.00% | – |
| Q1 2021 | $52,000 | +36.8% | 13,768 | 0.0% | 0.00% | – |
| Q4 2020 | $38,000 | -84.4% | 13,768 | +120.3% | 0.00% | – |
| Q3 2020 | $244,000 | – | 6,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|